Iconix Biosciences Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Latest Deal Type
-
Corporate
Iconix Biosciences General Information
Description
Provider of pharmaceutical research services intended to find the effect of virtual reality on the health industry. The company's services offer to select from a library of prerecorded VR operations, enabling medical students to study how VR affects daily lives.
Contact Information
Website
www.iconixbiosciences.comCorporate Office
- 325 East Middlefield Road
- Mountain View, CA 94043
- United States
Corporate Office
- 325 East Middlefield Road
- Mountain View, CA 94043
- United States
Iconix Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Corporate | 01-Nov-2015 | Completed | Generating Revenue | |||
| 10. Merger/Acquisition | 31-Aug-2007 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series I) | 24-Jan-2007 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series H) | 18-Dec-2006 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series G) | 30-Aug-2005 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series F) | 22-Mar-2002 | Completed | Startup | |||
| 5. Later Stage VC (Series E) | Completed | Startup | ||||
| 4. Later Stage VC (Series D) | 21-Mar-2002 | Completed | Startup | |||
| 3. Later Stage VC (Series C) | $9.8M | $19.6M | Completed | Startup | ||
| 2. Early Stage VC (Series B) | $3.23M | $9.8M | Completed | Startup |
Iconix Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series I | ||||||||
| Series H | ||||||||
| Series G2 | ||||||||
| Series G | ||||||||
| Series F2 | ||||||||
| Series F1 | ||||||||
| Series F | ||||||||
| Series E | ||||||||
| Series D | 3,018,770 | $0.001000 | $0.15 | $1.66 | $1.66 | 1x | $1.66 | 3.43% |
| Series C2 | 8,503,579 | $0.001000 | $0.1 | $1.12 | $1.12 | 1x | $1.12 | 9.65% |
Iconix Biosciences Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abingworth | Venture Capital | Minority | ||
| IVP | Venture Capital | Minority | ||
| Incyte Genomics | Corporation | Minority | ||
| Kleiner Perkins | Venture Capital | Minority | ||
| Lilly USA | Corporation | Minority |
Iconix Biosciences FAQs
-
When was Iconix Biosciences founded?
Iconix Biosciences was founded in 1997.
-
Where is Iconix Biosciences headquartered?
Iconix Biosciences is headquartered in Mountain View, CA.
-
What industry is Iconix Biosciences in?
Iconix Biosciences’s primary industry is Information Services (B2C).
-
Is Iconix Biosciences a private or public company?
Iconix Biosciences is a Private company.
-
What is Iconix Biosciences’s current revenue?
The current revenue for Iconix Biosciences is .
-
How much funding has Iconix Biosciences raised over time?
Iconix Biosciences has raised $80.6M.
-
Who are Iconix Biosciences’s investors?
Abingworth, IVP, Incyte Genomics, Kleiner Perkins, and Lilly USA are 5 of 11 investors who have invested in Iconix Biosciences.
-
When was Iconix Biosciences acquired?
Iconix Biosciences was acquired on 01-Nov-2015.
-
Who acquired Iconix Biosciences?
Iconix Biosciences was acquired by Entelos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
